Categories AlphaGraphs, Earnings, Other Industries

Earnings Preview: Booking Holdings might surprise with Q4 earnings growth owing to holiday season

Booking.com parent Booking Holdings Inc (BKNG) is expected to post its fourth-quarter 2018 earnings on Feb. 27 after the closing bell.

The travel itinerary giant has already beaten estimates in three out of four quarters — the one it fell short being the previously reported period.

For Q4, analysts estimate earnings of $19.39 a share on revenue of a little over $3 billion — hinting at about 15% year-over-year jump in both bottom line and top line.

Investors will be closely watching its international top-line growth — where the company’s chunk of revenue comes from, especially through its agency model.

Back home, Agoda and Rental Cars, respectively at agoda.com and rentalcars.com, are expected to boost merchant revenues. Robust operational measures are said to benefit the latter, while the former could see growth due to discounting.

For the to-be-reported quarter, room night growth is expected to see robust growth despite fierce domestic and international competition. Room night booked are expected to grow between 9% and 12%, while gross bookings are touted to jump 6-9% from last year.

 

LOOKING BACK

In the previously-reported third quarter, Booking Holdings’ merchant revenues soared 53.4% year over year.

The travel giant posted a 7% rise in earnings, while revenue grew 9.5%.

Booking Holdings third quarter 2018 Earnings Infographic

In the quarter, gross travel bookings jumped 12% to $24.3 billion.

Shortly after the results were announced, the stock soared over 8% during after-market trading.

With Merchant revenues pushing the results up the last time around, investors would be looking at how Booking Holdings would capitalize on the changing travel industry, with a heightened focus on its international market.

 

 

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top